Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 800 results for "alexion pharmaceuticals"

ALEXION PHARMACEUTICALS : New Data Presented at ASH Annual Mee...

By a News Reporter-Staff News Editor at Pharma Business Week -- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced that researchers presented data that continue to advance the understanding of atypical hemolytic uremic syndrome (aHUS) and ... 4 Traders, 1 day ago
[x]  

18 images for alexion pharmaceuticals

American Banking News, 2 hours ago
Cheshire Patch, 2 weeks ago
Cheshire Patch, 2 weeks ago
Hartford Business Journal, 4 days ago
Forbes.com, 2 days ago
Forbes.com, 2 days ago
Waterbury Republican American, 1 month ago
Waterbury Republican American, 1 month ago
FOX 61, 2 months ago
Securities Technology Monitor, 1 month ago

Alexion to buy back shares

News Editor Alexion Pharmaceuticals' (NASDAQ:ALXN) Board of Directors authorizes a share repurchase program of up to $500M. It will commence upon the completion of the currently authorized program of $400M which has
 Seeking Alpha4 days ago Alexion Announces New Share Repurchase Program of $500M  Zacks.com3 days ago Alexion Pharma To Repurchase Up To $500 Mln Of Stock - Quick Facts  RTTNews.com4 days ago
[x]  

Alexion Pharmaceuticals (ALXN) Showing Bearish Technicals With Support At $172.50

Alexion Pharmaceuticals Inc (http://www.marketintelligencecenter.com/symbol/ALXN"ALXN) presents a trading opportunity that offers a 5.78% return in just 65 days. A covered call on Alexion Pharmaceuticals at the $175.00 level expiring on Feb. '15 ...
 Individual.com2 days ago Potential Alexion Pharmaceuticals (ALXN) Trade Has 6.47% Downside Protection  TradingCharts.com4 days ago
[x]  

Alexion Pharmaceuticals Makes a Move: Down 2.1%

One of today's stocks on the move is Alexion Pharmaceuticals (NASDAQ:ALXN), down 2.1% to $179.40. The S&P is trading higher by 0.4% to 1,996 and the Dow is trading 0.4% higher
 Individual.com3 days ago Here's Why Alexion Pharmaceuticals (ALXN) Stock May Rise In Today's Holiday-Shortened Trading Session  Bidness Etc3 weeks ago Pharma Stocks To Watch: Alexion Pharmaceuticals (ALXN), Avanir Pharmaceuticals (AVNR), NewLink Genetics (NLNK), Merck and Co. (MRK)  Bidness Etc3 weeks ago

SmarTrend Watching for Potential Rebound in Shares of Alexion Pharmaceuticals After 2.99% Loss

(Comtex SmarTrend(R)) Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $177.16 to a high of $184.44. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $183.02 on volume ...
 Individual.com3 days ago Watch for Alexion Pharmaceuticals to Potentially Rebound After Falling 4.27% Yesterday  TradingCharts.com1 week ago SmarTrend Watching for Potential Pullback in Shares of Alexion Pharmaceuticals After 4.30% Gain  Individual.com2 weeks ago

Volume Spike Detected in Shares of Alexion Pharmaceuticals as They Move Lower on 1.4x Above-Average Volume (ALXN)

(Financial News Network On) Shares of Alexion Pharmaceuticals are trading down 0.8% to $181.80 today on above average volume. Today's volume of 1.3 million shares tops the average 30-day volume of 900,000 shares. Spikes in volume can validate a ...
 Individual.com3 days ago

19.2% Return Seen to Date on SmarTrend Alexion Pharmaceuticals Call (ALXN)

SmarTrend identified an Uptrend for Alexion Pharmaceuticals (NASDAQ:ALXN) on April 24th, 2014 at $156.80. In approximately 8 months, Alexion Pharmaceuticals has returned 19.20% as of today's recent price
 Individual.com1 week ago Alexion Pharmaceuticals Has Returned 25.1% Since SmarTrend Recommendation (ALXN)  TradingCharts.com2 weeks ago Uptrend Call Working As Alexion Pharmaceuticals Stock Rises 24.6% (ALXN)  TradingCharts.com3 weeks ago Alexion Pharmaceuticals Up 21.8% Since SmarTrend Uptrend Call (ALXN)  Individual.com4 weeks ago

Weekly CFO Sells Highlight: Alexion Pharmaceuticals Inc, Equity Residential, Tableau Software Inc.

According to GuruFocus Insider Data , the recent CFO sales were: Alexion Pharmaceuticals Inc, Equity Residential, and Tableau Software Inc. Alexion Pharmaceuticals Inc. (ALXN): EVP and CFO Vikas Sinha sold 75,000 shares On 12/03/2014, EVP and ...
 Yahoo! Finance1 week ago

Has Alexion Pharmaceuticals Healed From Its Bad Break?

Today well check in on Alexion Pharmaceuticals (NASDAQ: ALXN ), which develops therapeutics to treat hematologic and neurologic diseases and metabolic and inflammatory disorders. Its first commercial product, Soliris, comes with a hefty price tag of ...
 Investor's Business Daily4 weeks ago
[x]  

Hot Stock: Is Alexion's Pullback A Buy Opportunity?

With the market in a correction, several Sector Leaders are facing stiff selling pressure. Count Alexion Pharmaceuticals (ALXN), a member of Wednesday's screen, among them. Like many other growth stocks, Alexion's chart action in recent days has ...
 Town Hall2 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less